Michael A. Hast

835 total citations
20 papers, 668 citations indexed

About

Michael A. Hast is a scholar working on Molecular Biology, Neurology and Infectious Diseases. According to data from OpenAlex, Michael A. Hast has authored 20 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Infectious Diseases. Recurrent topics in Michael A. Hast's work include Botulinum Toxin and Related Neurological Disorders (7 papers), Neurological disorders and treatments (4 papers) and Peptidase Inhibition and Analysis (4 papers). Michael A. Hast is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (7 papers), Neurological disorders and treatments (4 papers) and Peptidase Inhibition and Analysis (4 papers). Michael A. Hast collaborates with scholars based in United States, Germany and Czechia. Michael A. Hast's co-authors include L.S. Beese, Homme W. Hellinga, Dennis Goldfarb, Kathleen M. Mulvaney, Michael B. Major, D. Neil Hayes, Priscila F. Siesser, Bridgid E. Hast, Feng Yan and Paul Modrich and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Michael A. Hast

20 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Hast United States 12 479 132 114 81 72 20 668
Jaeok Park Canada 17 516 1.1× 134 1.0× 124 1.1× 87 1.1× 36 0.5× 30 799
Chunshi Li China 17 302 0.6× 123 0.9× 218 1.9× 31 0.4× 40 0.6× 34 773
Kou Motani Japan 12 437 0.9× 50 0.4× 99 0.9× 49 0.6× 53 0.7× 17 678
Michele F. Rega United States 17 502 1.0× 92 0.7× 137 1.2× 34 0.4× 29 0.4× 28 762
Stephan Miller United States 6 419 0.9× 133 1.0× 79 0.7× 26 0.3× 25 0.3× 6 789
Julie Chen United States 7 732 1.5× 102 0.8× 43 0.4× 94 1.2× 100 1.4× 11 956
Richard Trilles United States 13 263 0.5× 65 0.5× 126 1.1× 62 0.8× 42 0.6× 17 486
Frédéric Thuaud France 13 754 1.6× 150 1.1× 202 1.8× 55 0.7× 45 0.6× 15 1.1k
Chad E. Schroeder United States 11 241 0.5× 37 0.3× 98 0.9× 81 1.0× 69 1.0× 20 538
Shih-Fong Chen United States 14 479 1.0× 110 0.8× 129 1.1× 132 1.6× 75 1.0× 22 727

Countries citing papers authored by Michael A. Hast

Since Specialization
Citations

This map shows the geographic impact of Michael A. Hast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Hast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Hast more than expected).

Fields of papers citing papers by Michael A. Hast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Hast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Hast. The network helps show where Michael A. Hast may publish in the future.

Co-authorship network of co-authors of Michael A. Hast

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Hast. A scholar is included among the top collaborators of Michael A. Hast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Hast. Michael A. Hast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hast, Michael A., et al.. (2024). Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea. Toxins. 16(8). 366–366. 2 indexed citations
3.
Jost, Wolfgang H., Petr Kaňovský, Michael A. Hast, et al.. (2023). Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults. Toxins. 15(6). 353–353. 1 indexed citations
4.
Comella, Cynthia, Robert A. Hauser, Stuart Isaacson, et al.. (2022). Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study. Clinical Parkinsonism & Related Disorders. 6. 100142–100142. 9 indexed citations
5.
6.
7.
Coleman, William P., et al.. (2017). Safety of IncobotulinumtoxinA in the Treatment of Facial Lines: Results From a Pooled Analysis of Randomized, Prospective, Controlled Clinical Studies. Dermatologic Surgery. 43(3). S293–S303. 7 indexed citations
8.
Hast, Michael A., et al.. (2015). Structures of theT. bruceikRNA editing factor MRB1590 reveal unique RNA-binding pore motif contained within an ABC-ATPase fold. Nucleic Acids Research. 43(14). 7096–7109. 14 indexed citations
9.
Juvvadi, Praveen R., Jarrod R. Fortwendel, Frédéric Lamoth, et al.. (2013). Phosphorylation of Calcineurin at a Novel Serine-Proline Rich Region Orchestrates Hyphal Growth and Virulence in Aspergillus fumigatus. PLoS Pathogens. 9(8). e1003564–e1003564. 44 indexed citations
10.
Mabanglo, Mark, Michael A. Hast, Nathan B. Lubock, Homme W. Hellinga, & L.S. Beese. (2013). Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design. Protein Science. 23(3). 289–301. 19 indexed citations
11.
Hast, Bridgid E., Dennis Goldfarb, Kathleen M. Mulvaney, et al.. (2013). Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination. Cancer Research. 73(7). 2199–2210. 215 indexed citations
12.
Mullen, Daniel G., et al.. (2012). Covalent protein–oligonucleotide conjugates by copper-free click reaction. Bioorganic & Medicinal Chemistry. 20(14). 4532–4539. 39 indexed citations
13.
Orans, Jillian, Michael A. Hast, Ravi R. Iyer, et al.. (2011). Purification, crystallization and preliminary X-ray diffraction analysis of the human mismatch repair protein MutSβ. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 67(8). 947–952. 3 indexed citations
14.
Orans, Jillian, Ravi Iyer, Michael A. Hast, et al.. (2011). Structures of Human Exonuclease 1 DNA Complexes Suggest a Unified Mechanism for Nuclease Family. Cell. 145(2). 212–223. 130 indexed citations
15.
Hast, Michael A., Connie B. Nichols, Shannon M. Kelly, et al.. (2011). Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens. Journal of Biological Chemistry. 286(40). 35149–35162. 43 indexed citations
16.
Fletcher, Steven, Erin P. Keaney, Michelle A. Blaskovich, et al.. (2010). Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents. Journal of Medicinal Chemistry. 53(19). 6867–6888. 40 indexed citations
17.
Hast, Michael A., Steven Fletcher, Michelle A. Blaskovich, et al.. (2009). Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein Farnesyltransferase. Chemistry & Biology. 16(2). 181–192. 29 indexed citations
18.
Hast, Michael A., et al.. (2008). Caged Protein Prenyltransferase Substrates: Tools for Understanding Protein Prenylation. Chemical Biology & Drug Design. 72(3). 171–181. 22 indexed citations
19.
Hast, Michael A. & L.S. Beese. (2008). Structure of Protein Geranylgeranyltransferase-I from the Human Pathogen Candida albicans Complexed with a Lipid Substrate. Journal of Biological Chemistry. 283(46). 31933–31940. 19 indexed citations
20.
Eastman, Richard T., John White, Oliver Hucke, et al.. (2006). Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase. Molecular and Biochemical Parasitology. 152(1). 66–71. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaeok Park Breakdown of academic impact, for papers by Chunshi Li Breakdown of academic impact, for papers by Kou Motani Breakdown of academic impact, for papers by Michele F. Rega Breakdown of academic impact, for papers by Stephan Miller Breakdown of academic impact, for papers by Julie Chen Breakdown of academic impact, for papers by Richard Trilles Breakdown of academic impact, for papers by Frédéric Thuaud Breakdown of academic impact, for papers by Chad E. Schroeder Breakdown of academic impact, for papers by Shih-Fong Chen
Rankless by CCL
2026